Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pCMV5-ALK2 wt Citations (1)

Originally described in: Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL J Biol Chem. 1998 Oct 2. 273(40):25628-36.
PubMed Journal

Articles Citing pCMV5-ALK2 wt

Therapeutic Efficacy of Immune Stimulatory Thymidine Kinase and fms-like Tyrosine Kinase 3 Ligand (TK/Flt3L) Gene Therapy in a Mouse Model of High-Grade Brainstem Glioma. Mendez F, Kadiyala P, Nunez FJ, Carney S, Nunez FM, Gauss JC, Ravindran R, Pawar S, Edwards M, Garcia-Fabiani MB, Haase S, Lowenstein PR, Castro MG. Clin Cancer Res. 2020 Aug 1;26(15):4080-4092. doi: 10.1158/1078-0432.CCR-19-3714. Epub 2020 Apr 24. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.